Robert Andtbacka on Managing Side Effects From T-VEC

Video

Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology, Department of Surgery, University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Rigors and chills are quite common, but can be managed fairly easily. If a patient experiences these side effects, Andtbacka says, a physician should premeditate him or her with Tylenol and antihistamines in future treatments. After 5-7 injections, the side effects usually go away completely.

Overall, T-VEC is very well tolerated and most patients can go to work and continue with other everyday activities.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop